Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O'Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

episode
The Real Chemistry Podcast not yet transcribed
▲ 0